Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation

Share :
Published: 1 Feb 2014
Views: 3720
Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France

Dr Rafael Sanchez-Salas talks to ecancer at the ASCO GU 2014 cancer congress.

Several indicators of intermittent androgen deprivation (IAD) outcomes in prostate cancer have been interpreted as potentially predictive, including prostate-specific antigen (PSA) nadir following first on-treatment period, off-phase interval duration and PSA doubling time. Improvement of the forecast of clinical outcomes is expected through identification and analysis of the different types of off-treatment period.